About BTS Research
BTS Research is a company based in San Diego (United States) founded in 2007 was acquired by PharmaLegacy Laboratories in September 2024. The company has 38 employees as of December 31, 2022. BTS Research offers products and services including In Vitro Services, Pharmacology Services, Toxicology Services, Disease Models, and Medical Device Testing. BTS Research operates in a competitive market with competitors including Gentronix, Shanghai Yaocheng Health Technology, Tigermed, ReveraGen and BioQual, among others.
- Headquarter San Diego, United States
- Employees 38 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bts Research
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
38
as on Dec 31, 2022
-
Acquired by
PharmaLegacy Laboratories
(Sep 16, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BTS Research
BTS Research offers a comprehensive portfolio of products and services, including In Vitro Services, Pharmacology Services, Toxicology Services, Disease Models, and Medical Device Testing.
Laboratory assays for drug discovery and mechanism studies.
Efficacy studies in disease models for pharmaceuticals.
Acute and repeated dose toxicology for regulatory compliance.
Models for inflammation, oncology, and metabolic diseases testing.
Testing for medical devices in preclinical settings.
Funding Insights of BTS Research
Detailed funding history for BTS Research
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in BTS Research
BTS Research has secured backing from 1 investor. Prominent investors backing the company include PharmaLegacy Laboratories.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Preclinical CRO offering in vivo models and services for a wide range of therapeutic areas
|
Locked | Locked | Locked |
Investor details for BTS Research
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BTS Research
Investment portfolio details for BTS Research
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BTS Research
Detailed financials for BTS Research
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bts Research Comparisons
Peer comparison for BTS Research
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BTS Research
BTS Research operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gentronix, Shanghai Yaocheng Health Technology, Tigermed, ReveraGen and BioQual, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
In-vitro and in-vivo genetic toxicology screening services are provided.
|
|
| Locked | Locked | Locked |
Clinical trial services to biopharma sector are provided.
|
|
| Locked | Locked | Locked |
Drug development and preclinical services are provided by Tigermed.
|
|
| Locked | Locked | Locked |
Steroids for Duchenne muscular dystrophy treatment are developed.
|
|
| Locked | Locked | Locked |
Contract research on infectious disease models is conducted.
|
|
| Locked | Locked | Locked |
Diversified preclinical services for brain-related disorders are provided.
|
Detailed competitors of BTS Research
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bts Research
Complete news archive for BTS Research
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BTS Research
BTS Research was founded in 2007.
BTS Research is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
As of Dec 31, 2022, the latest employee count at BTS Research is 38.
BTS Research is a preclinical CRO offering its services in North America, Asia, and Europe. Its services range from preclinical model development to IND-enabling studies. The company has disease models in therapeutic areas such as inflammation and autoimmunity, oncology and metabolic disorders and medical devices. They offer their services for the development of biologics, small molecules, and natural products. BTS Research can carry out preclinical trials in mice, rats, rabbits, guinea pigs, dogs, pigs, and 2 non-human primate species. The companys service portfolio includes pharmacology services (PKPD, ADME etc.,), Toxicology services, in-vitro assay services. BTS research is USDA and DEA registered, and AAALAC accredited.
BTS Research offers In Vitro Services, Pharmacology Services, Toxicology Services, Disease Models, and Medical Device Testing.
BTS Research has 1 investor. Key investors include PharmaLegacy Laboratories.